The FDA has approved the first over-the-counter fixed-dose combination tablet containing acetaminophen 650 mg and naproxen sodium 220 mg for pain relief in individuals aged 12 and older, with a claimed duration of up to 12 hours. The product combines two established analgesics into a single tablet previously available only as separate formulations. Sources confirm the approval but provide no comparative efficacy data against independent dosing.